Suppr超能文献

微环境细胞对淋巴瘤免疫的贡献。

Microenvironment Cell Contribution to Lymphoma Immunity.

作者信息

Kumar Deepika, Xu Mina L

机构信息

Departments of Pathology & Laboratory Medicine, Yale University School of Medicine, New Haven, CT, United States.

出版信息

Front Oncol. 2018 Jul 27;8:288. doi: 10.3389/fonc.2018.00288. eCollection 2018.

Abstract

Lymphoma microenvironment is a complex system composed of stromal cells, blood vessels, immune cells as well as extracellular matrix, cytokines, exosomes, and chemokines. In this review, we describe the function, localization, and interactions between various cellular components. We also summarize their contribution to lymphoma immunity in the era of immunotherapy. Publications were identified from searching Pubmed. Primary literature was carefully evaluated for replicability before incorporating into the review. We describe the roles of mesenchymal stem/stromal cells (MSCs), lymphoma-associated macrophages (LAMs), dendritic cells, cytotoxic T cells, PD-1 expressing CD4+ tumor infiltrating lymphocytes (TILs), T-cells expressing markers of exhaustion such as TIM-3 and LAG-3, regulatory T cells, and natural killer cells. While it is not in itself a cell, we also include a brief overview of the lymphoma exosome and how it contributes to anti-tumor effect as well as immune dysfunction. Understanding the cellular players that comprise the lymphoma microenvironment is critical to developing novel therapeutics that can help block the signals for immune escape and promote tumor surveillance. It may also be the key to understanding mechanisms of resistance to immune checkpoint blockade and immune-related adverse events due to certain types of immunotherapy.

摘要

淋巴瘤微环境是一个复杂的系统,由基质细胞、血管、免疫细胞以及细胞外基质、细胞因子、外泌体和趋化因子组成。在本综述中,我们描述了各种细胞成分的功能、定位及相互作用。我们还总结了它们在免疫治疗时代对淋巴瘤免疫的贡献。通过检索PubMed确定相关出版物。在纳入综述之前,对原始文献的可重复性进行了仔细评估。我们描述了间充质干/基质细胞(MSC)、淋巴瘤相关巨噬细胞(LAM)、树突状细胞、细胞毒性T细胞、表达PD-1的CD4+肿瘤浸润淋巴细胞(TIL)、表达如TIM-3和LAG-3等耗竭标志物的T细胞、调节性T细胞和自然杀伤细胞的作用。虽然淋巴瘤外泌体本身不是一种细胞,但我们也简要概述了它如何促进抗肿瘤作用以及导致免疫功能障碍。了解构成淋巴瘤微环境的细胞成分对于开发能够帮助阻断免疫逃逸信号并促进肿瘤监测的新型疗法至关重要。这也可能是理解对免疫检查点阻断的耐药机制以及某些类型免疫治疗引起的免疫相关不良事件的关键。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3a99/6073855/3381fbb8e64d/fonc-08-00288-g0001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验